Amphastar Pharmaceuticals, Inc. (AMPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 42.77 |
| Open | 42.84 |
| Bid | 42.05 x 100 |
| Ask | 42.26 x 200 |
| Day's range | 42.09 - 43.29 |
| 52-week range | 37.41 - 67.66 |
| Volume | |
| Avg. volume | 410,860 |
| Market cap | 2.063B |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | 16.23 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
Amphastar (AMPH) delivered earnings and revenue surprises of 35.06% and 0.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a rough three months with its share price down 19%. But if you pay...
- Zacks
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
Taysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.